Legislators in Colorado and Virginia have thwarted attempts to limit the powers of prescription drug affordability boards, which aim to control medicine prices. This development is significant for tech professionals involved in healthcare IT, as it may lead to increased demand for software that tracks and manages drug pricing. The next move will likely involve further legislative battles over how these boards operate and their impact on pharmaceutical costs.
Read the full article at STAT Pharma
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.





